» Articles » PMID: 34350955

Analysis on the Accuracy of CT-guided Radioactive I-125 Seed Implantation with 3D Printing Template Assistance in the Treatment of Thoracic Malignant Tumors

Overview
Journal J Radiat Res
Date 2021 Aug 5
PMID 34350955
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

This article analyzes the accuracy of needle track and dose of a 3-dimensional printing template (3DPT) in the treatment of thoracic tumor with radioactive I-125 seed implantation (RISI). A total of 28 patients were included. The technical process included: (i) preoperative CT positioning, (ii) preoperative planning design, (iii) 3DPT design and printing, (iv) 3DPT alignment, (v) puncture and seed implantation. The errors of needle position and dosimetric parameters were analyzed. A total of 318 needles were used. The mean errors in needle depth, needle insertion point, needle tip and needle angle were 0.52 ± 0.48 cm, 3.4 ± 1.7 mm, 4.4 ± 2.9 mm and 2.8 ± 1.7°, respectively. The differences between actual needle insertion angle and needle depth and those designed in the preoperative were statistically significant (p < 0.05). The mean values of all the errors of the chest wall cases were smaller than those of the lungs, and the differences were statistically significant (p < 0.05). There was no significant difference between the D90 calculated in the postoperative plan and those designed in the preoperative and intraoperative plans (p > 0.05). Some dosimetric parameters of preoperative plans such as V100, V200, CI and HI were not consistent with that of preoperative plans, and the difference was statistically significant (p < 0.05). However, there were no statistical difference in the dosimetric parameters between the postoperative plans and intraoperative plans (p > 0.05). We conclude that for thoracic tumors, even under the guidance of 3DPT, there will be errors. The plan should be optimized in real time during the operation.

Citing Articles

Experts consensus on 3D-printing template-assisted CT-guided radioactive iodine-125 seed implantation for recurrent soft tissue carcinoma in China.

Li M, Li X, Qiu B, Chen Y, Jiang P, Sun H Clin Exp Med. 2025; 25(1):52.

PMID: 39928184 PMC: 11811234. DOI: 10.1007/s10238-025-01575-5.


Experimental validation of the accuracy of robotic-assisted radioactive seed implantation for tumor treatment.

Ji Z, Wang Z, Jiang Y, Sun H, Qiu B, Li C J Robot Surg. 2024; 18(1):219.

PMID: 38771389 DOI: 10.1007/s11701-024-01957-z.


The Use of 3D Printing Technology in Gynaecological Brachytherapy-A Narrative Review.

Segedin B, Kobav M, Logar H Cancers (Basel). 2023; 15(16).

PMID: 37627193 PMC: 10452889. DOI: 10.3390/cancers15164165.

References
1.
Zhuang H, Wang J, Liao A, Wang J, Zhao Y . The biological effect of 125I seed continuous low dose rate irradiation in CL187 cells. J Exp Clin Cancer Res. 2009; 28:12. PMC: 2655271. DOI: 10.1186/1756-9966-28-12. View

2.
Wang H, Peng R, Li X, Wang Y, Jiang Y, Ji Z . The dosimetry evaluation of 3D printing non-coplanar template-assisted CT-guided 125I seed stereotactic ablation brachytherapy for pelvic recurrent rectal cancer after external beam radiotherapy. J Radiat Res. 2021; 62(3):473-482. PMC: 8127672. DOI: 10.1093/jrr/rraa144. View

3.
Wang H, Wang J, Jiang Y, Li J, Tian S, Ran W . The investigation of 125I seed implantation as a salvage modality for unresectable pancreatic carcinoma. J Exp Clin Cancer Res. 2013; 32:106. PMC: 3892087. DOI: 10.1186/1756-9966-32-106. View

4.
Rivard M, Coursey B, DeWerd L, Hanson W, Huq M, Ibbott G . Update of AAPM Task Group No. 43 Report: A revised AAPM protocol for brachytherapy dose calculations. Med Phys. 2004; 31(3):633-74. DOI: 10.1118/1.1646040. View

5.
Huang M, Liu S, Zheng L, Shi Y, Zhang J, Li Y . A digital model individual template and CT-guided 125I seed implants for malignant tumors of the head and neck. J Radiat Res. 2012; 53(6):973-7. PMC: 3483848. DOI: 10.1093/jrr/rrs046. View